Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of UTP20 mRNA] | CTD | PMID:31150632 | (-)-alpha-phellandrene | decreases expression | ISO | UTP20 (Homo sapiens) | 6480464 | alpha phellandrene results in decreased expression of UTP20 mRNA | CTD | PMID:25075043 | 1,2-dimethylhydrazine | affects expression | ISO | Utp20 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine affects the expression of UTP20 mRNA | CTD | PMID:22206623 | 1-chloro-2,4-dinitrobenzene | affects binding | ISO | UTP20 (Homo sapiens) | 6480464 | Dinitrochlorobenzene binds to UTP20 protein | CTD | PMID:32991956 | 17beta-estradiol | increases expression | ISO | UTP20 (Homo sapiens) | 6480464 | Estradiol results in increased expression of UTP20 mRNA | CTD | PMID:31614463 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | UTP20 (Homo sapiens) | 6480464 | [Triiodothyronine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of UTP20 mRNA | CTD | PMID:14761676 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of UTP20 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Utp20 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of UTP20 mRNA | CTD | PMID:19770486 | 3,3',5-triiodo-L-thyronine | multiple interactions | ISO | UTP20 (Homo sapiens) | 6480464 | [Triiodothyronine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of UTP20 mRNA | CTD | PMID:14761676 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | UTP20 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of UTP20 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of UTP20 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | UTP20 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of UTP20 mRNA | CTD | PMID:28628672 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of UTP20 mRNA | CTD | PMID:24780913 | aflatoxin B1 | increases expression | ISO | Utp20 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of UTP20 mRNA | CTD | PMID:19770486 | all-trans-retinoic acid | decreases expression | ISO | UTP20 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of UTP20 mRNA | CTD | PMID:15498508 and PMID:33167477 | alpha-phellandrene | decreases expression | ISO | UTP20 (Homo sapiens) | 6480464 | alpha phellandrene results in decreased expression of UTP20 mRNA | CTD | PMID:25075043 | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of UTP20 mRNA | CTD | PMID:30779732 | aristolochic acid A | decreases expression | ISO | UTP20 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of UTP20 mRNA | CTD | PMID:33212167 | Aroclor 1254 | decreases expression | ISO | Utp20 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of UTP20 mRNA | CTD | PMID:23650126 | benzo[a]pyrene | increases expression | ISO | Utp20 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of UTP20 mRNA | CTD | PMID:19770486 | benzo[a]pyrene | affects methylation | ISO | UTP20 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of UTP20 promoter | CTD | PMID:27901495 | benzo[a]pyrene diol epoxide I | increases expression | ISO | UTP20 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:26238291 | bisphenol A | increases expression | ISO | Utp20 (Mus musculus) | 6480464 | bisphenol A results in increased expression of UTP20 mRNA | CTD | PMID:26063408 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Genistein] results in increased methylation of UTP20 gene | CTD | PMID:28505145 | bisphenol A | multiple interactions | ISO | UTP20 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of UTP20 mRNA | CTD | PMID:28628672 | cadmium atom | multiple interactions | ISO | UTP20 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UTP20 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | UTP20 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UTP20 mRNA | CTD | PMID:35301059 | carbon nanotube | increases expression | ISO | Utp20 (Mus musculus) | 6480464 | Nanotubes and Carbon results in increased expression of UTP20 mRNA | CTD | PMID:25554681 | CGP 52608 | multiple interactions | ISO | UTP20 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to UTP20 gene] | CTD | PMID:28238834 | chlorpyrifos | decreases expression | ISO | Utp20 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of UTP20 mRNA | CTD | PMID:37019170 | chromium(6+) | affects expression | ISO | Utp20 (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of UTP20 mRNA | CTD | PMID:28472532 | cisplatin | decreases expression | ISO | UTP20 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of UTP20 mRNA | CTD | PMID:27594783 | cisplatin | multiple interactions | ISO | UTP20 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of UTP20 mRNA | CTD | PMID:27392435 | clofibrate | decreases expression | ISO | Utp20 (Mus musculus) | 6480464 | Clofibrate results in decreased expression of UTP20 mRNA | CTD | PMID:17585979 | copper(II) sulfate | increases expression | ISO | UTP20 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of UTP20 mRNA | CTD | PMID:19549813 | cyclosporin A | decreases expression | ISO | UTP20 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of UTP20 mRNA | CTD | PMID:25562108 | dexamethasone | multiple interactions | ISO | UTP20 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of UTP20 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of UTP20 mRNA | CTD | PMID:28628672 | dioxygen | multiple interactions | ISO | Utp20 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of UTP20 mRNA | CTD | PMID:30529165 | epoxiconazole | decreases expression | ISO | Utp20 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of UTP20 mRNA | CTD | PMID:35436446 | ethyl methanesulfonate | decreases expression | ISO | UTP20 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in decreased expression of UTP20 mRNA | CTD | PMID:23649840 | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of UTP20 mRNA | CTD | PMID:24136188 | flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of UTP20 mRNA | CTD | PMID:24793618 | FR900359 | increases phosphorylation | ISO | UTP20 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of UTP20 protein | CTD | PMID:37730182 | genistein | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Genistein] results in increased methylation of UTP20 gene | CTD | PMID:28505145 | glyphosate | affects methylation | EXP | | 6480464 | Glyphosate affects the methylation of UTP20 gene | CTD | PMID:35440735 | hydrogen peroxide | affects expression | ISO | UTP20 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of UTP20 mRNA | CTD | PMID:20044591 | indometacin | multiple interactions | ISO | UTP20 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of UTP20 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of UTP20 mRNA | CTD | PMID:28628672 | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of UTP20 gene | CTD | PMID:35440735 | methyl methanesulfonate | decreases expression | ISO | UTP20 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of UTP20 mRNA | CTD | PMID:23649840 | N-ethyl-N-nitrosourea | increases mutagenesis | ISO | Utp20 (Mus musculus) | 6480464 | Ethylnitrosourea results in increased mutagenesis of UTP20 intron | CTD | PMID:27776689 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of UTP20 mRNA | CTD | PMID:25729387 | paracetamol | affects expression | ISO | Utp20 (Mus musculus) | 6480464 | Acetaminophen affects the expression of UTP20 mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of UTP20 mRNA | CTD | PMID:33387578 | paracetamol | decreases expression | ISO | UTP20 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of UTP20 mRNA | CTD | PMID:29067470 | paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of UTP20 mRNA | CTD | PMID:32680482 | perfluorononanoic acid | increases expression | ISO | UTP20 (Homo sapiens) | 6480464 | perfluoro-n-nonanoic acid results in increased expression of UTP20 mRNA | CTD | PMID:32588087 | potassium dichromate | decreases expression | ISO | UTP20 (Homo sapiens) | 6480464 | Potassium Dichromate results in decreased expression of UTP20 protein | CTD | PMID:23718831 | quercetin | decreases expression | ISO | UTP20 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of UTP20 mRNA | CTD | PMID:21632981 | resveratrol | multiple interactions | ISO | UTP20 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of UTP20 mRNA | CTD | PMID:23557933 | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of UTP20 mRNA | CTD | PMID:28374803 | sodium dichromate | increases expression | EXP | | 6480464 | sodium bichromate results in increased expression of UTP20 mRNA | CTD | PMID:25993096 | tamibarotene | decreases expression | ISO | UTP20 (Homo sapiens) | 6480464 | tamibarotene results in decreased expression of UTP20 mRNA | CTD | PMID:15498508 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of UTP20 mRNA | CTD | PMID:31150632 | tetrachloromethane | increases expression | ISO | Utp20 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of UTP20 mRNA | CTD | PMID:31919559 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of UTP20 mRNA] | CTD | PMID:31150632 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of UTP20 mRNA | CTD | PMID:23411599 and PMID:34492290 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of UTP20 mRNA | CTD | PMID:25729387 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of UTP20 mRNA | CTD | PMID:33387578 | trichostatin A | increases expression | ISO | UTP20 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of UTP20 mRNA | CTD | PMID:24935251 | trimellitic anhydride | increases expression | ISO | Utp20 (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of UTP20 mRNA | CTD | PMID:19042947 | triptonide | decreases expression | ISO | Utp20 (Mus musculus) | 6480464 | triptonide results in decreased expression of UTP20 mRNA | CTD | PMID:33045310 | tungsten | decreases expression | ISO | Utp20 (Mus musculus) | 6480464 | Tungsten results in decreased expression of UTP20 mRNA | CTD | PMID:30912803 | urethane | decreases expression | ISO | UTP20 (Homo sapiens) | 6480464 | Urethane results in decreased expression of UTP20 mRNA | CTD | PMID:28818685 | valproic acid | decreases expression | ISO | Utp20 (Mus musculus) | 6480464 | Valproic Acid results in decreased expression of UTP20 mRNA | CTD | PMID:21427059 | valproic acid | decreases methylation | ISO | UTP20 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of UTP20 gene | CTD | PMID:29154799 | valproic acid | increases expression | ISO | UTP20 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of UTP20 mRNA | CTD | PMID:23179753 | valproic acid | affects expression | ISO | UTP20 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of UTP20 mRNA | CTD | PMID:25979313 | vitamin E | decreases expression | ISO | UTP20 (Homo sapiens) | 6480464 | Vitamin E results in decreased expression of UTP20 mRNA | CTD | PMID:19244175 | |